A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival have?
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival has 40 citations in the OpenAlex counts ScholarIQ stores.
When was A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival published?
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival has 2022 year in the ScholarIQ index.
What is the open-access status of A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival?
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival has hybrid oa status in the ScholarIQ index.
What is the DOI of A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival?
The DOI for A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival is on the source record.
What is the PMID of A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival?
The PMID for A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival is on the source record.
What is the OpenAlex record for A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival?
The OpenAlex for A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival is on the source record.